Coronary Artery Disease with Diabetes
FREEDOM Trial
Future Revascularization in Patients with Diabetes Mellitus: Optimal Management of Multivessel Disease
Principal Investigator
Donald E. Cutlip, MD
Co-Investigators
Charles Dow, MD
Robert C. Hagberg, MD
Kalon Ho, MD
Roger J. Laham, MD
David E. Leeman, MD
Duane S. Pinto, MD
Samuel J. Shubrooks, Jr., MD
Coordinator
Paula Rooney, RN
Phone: 617-632-7484
Email: prooney@bidmc.harvard.edu
Focus: Coronary artery disease patients with diabetes
The FREEDOM trial is evaluating whether drug-eluting stenting (DES) is more or less effective than coronary artery bypass grafting (CABG) in multi-vessel coronary artery disease (CAD) in patients with diabetes.
